Literature DB >> 836697

Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments.

P M Elias, P Fritsch, E H Epstein.   

Abstract

The essential clinical features of staphylococcal scalded skin syndrome (SSSS) and otherforms of toxic epidermal necrolysis (TEN) are contrasted. Whereas TEN is a devastating disease of multiple causes and of high fatality affecting all age groups, SSSS comprises many clinical entitles that occur primarily in early childhood and is caused by certain phage group 2 staphylococci. Because of the high cleavage plane, the barrier is only translently perturbed, and rapid recovery is the rule. Although the early stages of SSSS may resemble other widespread dermatoses clinically, the correct diagnosis is suggested, even prior to frank exfoliation, by the presence of cutaneous tenderness and a positive Nikolski sign. However, rapid bedside confirmation is now possible with exfoliative cytology and frozen sections. Recent availability of in vivo and in vitro animal models of SSSS have advanced the knowledge of the disease: the responsible epidermolytic toxin has been characterized, and the purely extracellular pathogenesis of SSSS has been established. The epidermolytic toxin is strikingly species and tissue specific, attacking only certain keratinizing epithelia of mice, hamsters, monkeys, and man. The lower incidence of SSSS in adults is primarily due to a supreior capacity to metabolize and excrete the toxin, as well as more efficient immune capabilities. The mechanisms of epidermolytic toxin action and the molecular site of action are still the focus of active investigation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836697     DOI: 10.1001/archderm.113.2.207

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  21 in total

1.  Staphylococcal scalded skin syndrome in a preterm newborn presenting within first 24 h of life.

Authors:  Prem Arora; Vaneet Kumar Kalra; Sharayu Rane; Eric J McGrath; Ricardo Zegarra-Linares; Sanjay Chawla
Journal:  BMJ Case Rep       Date:  2011-12-21

Review 2.  [Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

3.  The esterolytic activity of epidermolytic toxins.

Authors:  C J Bailey; M B Redpath
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 4.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

5.  Staphylococcal scalded skin syndrome in a neonate.

Authors:  J Raymond; E Bingen; N Brahimi; M Bergeret; J Lepercq; J Badoual; D Gendrel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

6.  Staphylococcal scalded skin syndrome.

Authors:  R Jackson
Journal:  Can Med Assoc J       Date:  1977-10-22       Impact factor: 8.262

7.  The binding of epidermolytic toxin from Staphylococcus aureus to mouse epidermal tissue.

Authors:  T P Smith; D A John; C J Bailey
Journal:  Histochem J       Date:  1987-03

8.  An innovative local treatment for staphylococcal scalded skin syndrome.

Authors:  E Mueller; M Haim; T Petnehazy; B Acham-Roschitz; M Trop
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-01       Impact factor: 3.267

9.  Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.

Authors:  Takayuki Yamaguchi; Koji Nishifuji; Megumi Sasaki; Yasuyuki Fudaba; Martin Aepfelbacher; Takashi Takata; Masaru Ohara; Hitoshi Komatsuzawa; Masayuki Amagai; Motoyuki Sugai
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 10.  The epidermolytic (exfoliative) toxins of Staphylococcus aureus.

Authors:  C J Bailey; B P Lockhart; M B Redpath; T P Smith
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.